Lazard Asset Management LLC Athenex, Inc. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$11.06 - $14.01 $70,242 - $88,977	-6,351 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$10.26 - $14.55 $7,387 - $10,476	-720 Reduced 10.18%	6,351 $76,000
Q2 2020 Aug 13, 2020	SELL	$7.11 - $13.76 $17,583 - $34,028	-2,473 Reduced 25.91%	7,071 $97,000
Q1 2020 May 14, 2020	BUY	$5.71 - $15.85 $54,496 - $151,272	9,544 New	9,544 $73,000
Q2 2018 Aug 13, 2018	SELL	$15.88 - $19.5 $669,691 - $822,354	-42,172 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$13.53 - $17.47 $570,587 - $736,744	42,172 New	42,172 $717,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.